Please Wait
Applying Filters...
menu
    • menu

    Digital Content for MolPort-002-056-760

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    MolPort-002-056-760

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 37Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Castle Creek Announces License of Exclusive US Rights for Arlevert
    Castle Creek Announces License of Exclusive US Rights for Arlevert

    14 Dec 2016

    // BUSINESS WIRE

    http://www.businesswire.com/news/home/20161213005394/en/Castle-Creek-Pharmaceuticals-Announces-License-Exclusive-U.S.

    BUSINESS WIRE
    14 Dec 2016
    Share Share
    Enhanced bioavailability of cinnarizine nanosuspensions by particle size engineering: Optimization and physicochemical investigations
    Enhanced bioavailability of cinnarizine nanosuspensions by particle size engineering: Optimization and physicochemical investigations

    24 Feb 2016

    // PHARMA-EXCIPIENTS

    http://www.pharma-excipients.ch/2016/02/24/enhanced-bioavailability-of-cinnarizine-nanosuspensions-by-particle-size-engineering-optimization-and-physicochemical-investigations/

    PHARMA-EXCIPIENTS
    24 Feb 2016
    Share Share